Kintara Therapeutics Inc - Received a Letter From Nasdaq Advising That Company Had Been Granted a 180-Day Extension to December 9
kintara therapeutics公司收到納斯達克的通知,稱該公司已被授予180天的延期,截至12月9日
Kintara Therapeutics Inc - Received a Letter From Nasdaq Advising That Company Had Been Granted a 180-Day Extension to December 9
kintara therapeutics公司收到納斯達克的通知,稱該公司已被授予180天的延期,截至12月9日
使用瀏覽器的分享功能,分享給你的好友吧